Literature DB >> 10233680

An antiserum raised against the recombinant cytoplasmic tail of the human CD43 glycoprotein identifies CD43 in many mammalian species.

T Szlanka1, G K Toth, I Ocsovszki, G Keresztes.   

Abstract

Leukosialin or CD43 is a heavily O-glycosylated transmembrane protein expressed on all cells of the haematopoietic cell lineage with the exception of red blood cells and mature B cells. This antigen has been identified in human, mouse and rat with monoclonal antibodies. Although orthologues of many human and rodent leucocyte cell surface antigens have been described in recent years, CD43, despite its abundance on human and rodent cells, remained uncharacterized in other vertebrate species. The comparison of CD43 amino acid sequences from human, mouse and rat indicated a high level of homology in the cytoplasmic domain. A serum, (p.aCD43cp) raised against the recombinant cytoplasmic tail of the human CD43, was shown not only to recognize human CD43, but it bound to putative CD43 orthologues in many mammalian species. CD43 was found to be expressed in the same leucocyte subpopulations and circumstantial evidence suggested that CD43 is also regulated similarly during leucocyte ontogeny in all species investigated. As CD43+ cells were readily observed in fixed tissues, the p.aCD43cp serum may be used as a reliable reagent for the verification of the haematopoietic origin of infiltrations and, used together with other reagents, for the serological characterization of normal and pathological lymphoid tissues and lymphoid infiltrations in experimental work and in animal disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233680      PMCID: PMC2326724          DOI: 10.1046/j.1365-2567.1999.00604.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.

Authors:  Y Rosenstein; J K Park; W C Hahn; F S Rosen; B E Bierer; S J Burakoff
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

2.  An antiserum reacts with an evolutionary conserved region in the epsilon subunit of the T-cell receptor-CD3 complex in phylogenetically distant species.

Authors:  E Kurucz; R Glavits; L Krenacs; T Krenacs; I Ocsovszky; G Keresztes; E Monostori; I Ando
Journal:  Immunol Lett       Date:  1993-10       Impact factor: 3.685

3.  CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.

Authors:  V Bazil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation.

Authors:  P Rieu; F Porteu; G Bessou; P Lesavre; L Halbwachs-Mecarelli
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

5.  The importance of cross-linking in the homotypic aggregation of lymphocytes induced by anti-leukosialin (CD43) antibodies.

Authors:  J G Cyster; A F Williams
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

6.  Analyses of anti-human CD monoclonal antibodies for cross reactions with swine cell antigens.

Authors:  J K Lunney; K Walker; T Goldman
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

7.  Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies.

Authors:  M Jones; J L Cordell; A D Beyers; A G Tse; D Y Mason
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

8.  Characterization of the activation-associated isoform of CD43 on murine T lymphocytes.

Authors:  A T Jones; B Federsppiel; L G Ellies; M J Williams; R Burgener; V Duronio; C A Smith; F Takei; H J Ziltener
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

9.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.

Authors:  F Piller; F Le Deist; K I Weinberg; R Parkman; M Fukuda
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

10.  Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.

Authors:  J C Lefebvre; V Giordanengo; M Limouse; A Doglio; M Cucchiarini; F Monpoux; R Mariani; J F Peyron
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.